These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38593870)

  • 1. Targeting inhibitory Siglec-3 to suppress IgE-mediated human basophil degranulation.
    Barshow SM; Islam M; Commins S; Macauley MS; Paulson JC; Kulis MD
    J Allergy Clin Immunol; 2024 Aug; 154(2):492-497.e1. PubMed ID: 38593870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients.
    Hayen SM; den Hartog Jager CF; Knulst AC; Knol EF; Garssen J; Willemsen LEM; Otten HG
    Front Immunol; 2018; 9():1265. PubMed ID: 29942305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy.
    Castaño N; Chua K; Kaushik A; Kim S; Cordts SC; Nafarzadegan CD; Hofmann GH; Seastedt H; Schuetz JP; Dunham D; Parsons ES; Tsai M; Cao S; Desai M; Sindher SB; Chinthrajah RS; Galli SJ; Nadeau KC; Tang SKY
    Allergy; 2024 Feb; 79(2):445-455. PubMed ID: 37916710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.
    Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM
    J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy.
    Suber J; Zhang Y; Ye P; Guo R; Burks AW; Kulis MD; Smith SA; Iweala OI
    Front Immunol; 2022; 13():974374. PubMed ID: 36248809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
    Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
    J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation.
    Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG
    Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF; Du Toit G; Douiri A; Radulovic S; Stephens A; Turcanu V; Lack G
    J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.
    El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC
    Front Immunol; 2022; 13():881655. PubMed ID: 35865546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruiting CD33 on mast cells to inhibit IgE-mediated mast cell-dependent anaphylaxis.
    Galli SJ
    J Clin Invest; 2019 Mar; 129(3):955-957. PubMed ID: 30776022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.
    MacGlashan DW; Savage JH; Wood RA; Saini SS
    J Allergy Clin Immunol; 2012 Nov; 130(5):1130-1135.e5. PubMed ID: 22800400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis.
    Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C
    Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing of the basophil activation test: Comparison of different basophil identification markers.
    Eberlein B; Hann R; Eyerich S; Pennino D; Ring J; Schmidt-Weber CB; Buters J
    Cytometry B Clin Cytom; 2015; 88(3):183-9. PubMed ID: 25399741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.
    Duan S; Arlian BM; Nycholat CM; Wei Y; Tateno H; Smith SA; Macauley MS; Zhu Z; Bochner BS; Paulson JC
    J Immunol; 2021 May; 206(10):2290-2300. PubMed ID: 33911007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis.
    Mukai K; Gaudenzio N; Gupta S; Vivanco N; Bendall SC; Maecker HT; Chinthrajah RS; Tsai M; Nadeau KC; Galli SJ
    J Allergy Clin Immunol; 2017 Mar; 139(3):889-899.e11. PubMed ID: 27527263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
    Thyagarajan A; Jones SM; Calatroni A; Pons L; Kulis M; Woo CS; Kamalakannan M; Vickery BP; Scurlock AM; Wesley Burks A; Shreffler WG
    Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecule cross-linking and cytokine exposure modulate IgE- and non-IgE-dependent basophil activation.
    Kalm F; Mansouri L; Russom A; Lundahl J; Nopp A
    Immunology; 2021 Jan; 162(1):92-104. PubMed ID: 32955733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy.
    Larsen LF; Juel-Berg N; Hansen KS; Clare Mills EN; van Ree R; Poulsen LK; Jensen BM
    Allergy; 2018 Jan; 73(1):137-144. PubMed ID: 28686296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.